| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 190,864 | 302,219 | 271,864 | 171,272 | | Cost of Revenue | 131,287 | 192,371 | 155,683 | 111,184 | | | Gross Profit | 59,577 | 109,848 | 116,181 | 60,088 | | | Operating Expenses | | Research Development | 7,727 | 7,837 | 8,103 | 7,258 | | Selling General and Administrative | 77,424 | 91,752 | 94,637 | 81,443 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (25,574) | 10,259 | 13,441 | (28,613) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 837 | 512 | (2,381) | 21,785 | | Earnings Before Interest And Taxes | (24,737) | 10,771 | 11,060 | (6,828) | | Interest Expense |
-
|
-
|
-
| 1,092 | | Income Before Tax | (24,737) | 10,771 | 11,060 | (7,920) | | Income Tax Expense | (11,308) | 3,859 | 4,248 | (4,766) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,429) | 6,912 | 6,812 | (3,154) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,429) | 6,912 | 6,812 | (3,154) | | Preferred Stock And Other Adjustments | (2,625) | (438) |
-
|
-
| | | Net Income Applicable To Common Shares | ($16,054) | $6,474 | $6,812 | ($3,154) |
|
0.22% Nasdaq 
Income Statement
